Lunch (12:00 PM): 35g protein
While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions
If its right for you, its possible to get coverage
Another study took place between September 2021 to late November 2022, in a total of 272 participants underwent adaptive randomization
Clinical trials and our own patient experiences show that tirzepatide can help you achieve gradual, ongoing weight loss over several months
UPS Ground, tracked + insured